T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge
Scroll Down
The company was created to harness the power of T cell biology, evolved over millions of years, to create safe and effective treatments for many cancers and autoimmune diseases.
We combine world-leading expertise in mouse genome engineering, deep expertise in biopharmaceutical drug development, single cell genomics, machine-learning and structural biology, anchored in a culture of creativity and collaboration.
We are developing ‘optimal’ TCR based therapeutics using our proprietary OpTiMus® platform, based on a fully humanised TCR mouse that provides an almost unlimited source of unique, antigen-specific human TCRs. These TCRs are directed at multiple target classes, many of which have never been worked on before.
Scroll Down
T-Therapeutics is developing a pipeline of first-in-class drugs that will become transformative medicines, reshaping the clinical landscape for patients with cancer or autoimmune diseases.
Scroll Down
Investors
Scroll Down
Meet the Team
Leadership Team
Board of Directors
Scroll Down
Why T-Therapeutics
We are an ambitious organisation with a strong heritage and commitment to world-leading scientific excellence.
Careers
T-Therapeutics is at the forefront of cutting-edge innovation in the field of T cell receptor-based medicines designed to leverage the power of T cells for therapeutic benefit.
We are an ambitious organisation with a strong heritage and commitment to world-leading scientific excellence. Our employees thrive within an intellectually rich culture of creativity and collaboration, sparking the innovative spirit and creative genius that drive us forward.
If you’re inspired by groundbreaking science, teamwork, and the opportunity to make a real difference for patients with life-threatening conditions, please get in contact with us.
Interested in joining our team?
Please send your CV along with a cover letter to jobs@t-therapeutics.com
T-Therapeutics is an Equal Opportunity employer.
We will consider all applicants without discrimination on grounds of disability, sexual orientation, pregnancy or maternity leave status, race or national or ethnic origin, age, religion or belief, gender identity or re-assignment, marital or civil partnership status, protected veteran status (if applicable) or any other characteristic protected by law. The ability to perform the job will be the primary consideration.
Scroll Down
Pioneering precision medicine, we seamlessly bridge lab breakthroughs to clinical success, unlocking the immune system’s potential for personalised cancer and autoimmune solutions.
Dr. Ruben Cabanillas MD, PhD
Senior Director of Translational Medicine
